Marie A. Fadden

FDA investigator

Appears on 8 documents from 2004 to 2015, mostly at sites in Wisconsin. Most often cites testing and release for distribution (21 CFR 211.165).

8
Documents on file
22.8
Observations per 483
2004
First seen
2015
Most recent

What they cite most

From 110 observations

Activity by year

2004: 1, 2009: 3, 2011: 1, 2013: 2, 2015: 1

Where

Wisconsin 5 · Alabama 1 · Indiana 1 · Minnesota 1

Is Marie A. Fadden coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

8 documents, newest first
FirmOpen
Response Triad GroupJul 11, 2015 · Hartland, Wisconsin
483 Nora Apothecary and Alternative Therapies, Inc.Mar 21, 2013 · Indianapolis, Indiana
483 Central Admixture Pharmacy Services, Inc. (CAPS)Mar 7, 2013 · Homewood, Alabama
483 H & P Industries, Inc.Jan 7, 2011 · Hartland, Wisconsin
483 H & P Industries, Inc. dba Triad GroupJul 17, 2009 · Hartland, Wisconsin
EIR H & P Industries, Inc. dba Triad GroupJul 17, 2009 · Hartland, Wisconsin
483 Scientific Protein LaboratoriesMay 8, 2009 · Waunakee, Wisconsin

About this profile

What does Marie A. Fadden inspect?

Marie A. Fadden appears on 8 documents on file covering 6 sites, mostly in Wisconsin.

What do they cite most often?

21 CFR 211.165 (testing and release for distribution), followed by 21 CFR 211.110 and 21 CFR 211.160(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Marie A. Fadden is dated Jul 11, 2015.